Learn more about the upcoming new radionuclide family of Scandium: Sc-44/Sc-47 or Sc-43/Sc-47 pairs are appealing true theranostic radionuclides for nuclear medicine. Standardized procedures for scandium-based radiopharmaceuticals have been proposed as a basis to pave the way for elaboration of the Ph.Eur. monographs for perspective scandium radionuclides.
Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements - R. Mikolajczak1, S. Huclier-Markai, C. Alliot, F. Haddad, D. Szikra, V. Forgacs and P. Garnuszek1Other news & events
- News12.05.2026
#ASCO26 - Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing Oncologists
Read more - News11.05.2026
Oncidium foundation partners with Curium to expand access to Radioligand Therapy worldwide
Read more - News22.04.2026
Addressing Barriers to Radioligand Therapy at the European Parliament
Read more
